Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Seco-sativene sesquiterpenoids are a specialized class of C15 fungal secondary metabolites characterized by a cleaved (seco-) sativene carbon skeleton. They are primarily produced by filamentous fungi in the genera Bipolaris, Cochliobolus, and Drechslera, which are known phytopathogens. These molecules are synthesized through the cyclization of farnesyl pyrophosphate into a sativene intermediate, followed by oxidative ring cleavage mediated by cytochrome P450 enzymes. Biologically, seco-sativene sesquiterpenoids are significant for their phytotoxic properties, which assist fungi in colonizing host plants by inducing necrosis or inhibiting growth. Beyond their role in plant pathology, some derivatives have shown antimicrobial and cytotoxic activities in pharmacological screens, marking them as scaffolds of interest for natural product chemistry and potential pesticide development. However, they are not classified as therapeutic targets themselves, but rather as bioactive chemical entities produced by biological sources.
As secondary metabolites, these compounds do not have a therapeutic mechanism of action on human targets; instead, they often act as phytotoxins that disrupt plant cell membranes or interfere with plant growth regulation during infection (e.g., via the inhibition of seed germination or induction of chlorosis).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Seco-sativene sesquiterpenoids.